193 related articles for article (PubMed ID: 7505364)
1. Receptor mechanism of thrombin-induced endothelium-dependent and endothelium-independent coronary vascular effects in dogs.
Ku DD; Zaleski JK
J Cardiovasc Pharmacol; 1993 Oct; 22(4):609-16. PubMed ID: 7505364
[TBL] [Abstract][Full Text] [Related]
2. Effects of NG-substituted arginines on coronary vascular function after endotoxin.
Winn MJ; Vallet B; Asante NK; Curtis SE; Cain SM
J Appl Physiol (1985); 1993 Jul; 75(1):424-31. PubMed ID: 7690746
[TBL] [Abstract][Full Text] [Related]
3. Involvement of the "tethered ligand" receptor in thrombin-induced endothelium-mediated relaxations.
Tesfamariam B; Allen GT; Normandin D; Antonaccio MJ
Am J Physiol; 1993 Nov; 265(5 Pt 2):H1744-9. PubMed ID: 8238588
[TBL] [Abstract][Full Text] [Related]
4. Relaxant and contractile responses of porcine pulmonary arteries to a thrombin receptor activating peptide (TRAP).
Glusa E; Paintz M
Naunyn Schmiedebergs Arch Pharmacol; 1994 Apr; 349(4):431-6. PubMed ID: 8058115
[TBL] [Abstract][Full Text] [Related]
5. Thimerosal blocks stimulated but not basal release of endothelium-derived relaxing factor (EDRF) in dog isolated coronary artery.
Crack P; Cocks T
Br J Pharmacol; 1992 Oct; 107(2):566-72. PubMed ID: 1384915
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.
Stork AP; Cocks TM
Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260
[TBL] [Abstract][Full Text] [Related]
7. Distinct receptors and signaling pathways in alpha-thrombin- and thrombin receptor peptide-induced vascular contractions.
Tesfamariam B
Circ Res; 1994 May; 74(5):930-6. PubMed ID: 8156640
[TBL] [Abstract][Full Text] [Related]
8. Evidence for differential roles of nitric oxide (NO) and hyperpolarization in endothelium-dependent relaxation of pig isolated coronary artery.
Kilpatrick EV; Cocks TM
Br J Pharmacol; 1994 Jun; 112(2):557-65. PubMed ID: 7521260
[TBL] [Abstract][Full Text] [Related]
9. Vascular actions of thrombin receptor-derived polypeptides: structure-activity profiles for contractile and relaxant effects in rat aorta.
Laniyonu AA; Hollenberg MD
Br J Pharmacol; 1995 Apr; 114(8):1680-6. PubMed ID: 7541284
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of thrombin-induced endothelium-dependent coronary vasodilation in dogs: role of its proteolytic enzymatic activity.
Ku DD
J Cardiovasc Pharmacol; 1986; 8(1):29-36. PubMed ID: 2419689
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hypoxia-induced relaxation of rabbit isolated coronary arteries by NG-monomethyl-L-arginine but not glibenclamide.
Jiang C; Collins P
Br J Pharmacol; 1994 Mar; 111(3):711-6. PubMed ID: 8019749
[TBL] [Abstract][Full Text] [Related]
12. Thrombin receptor-mediated vascular relaxation differentiated by a receptor antagonist and desensitization.
Tesfamariam B
Am J Physiol; 1994 Nov; 267(5 Pt 2):H1962-7. PubMed ID: 7526715
[TBL] [Abstract][Full Text] [Related]
13. Chronic inhibition of NO synthase enhances the production of prostacyclin in coronary arteries through upregulation of the cyclooxygenase type 1 isoform.
Beverelli F; Béa ML; Puybasset L; Giudicelli JF; Berdeaux A
Fundam Clin Pharmacol; 1997; 11(3):252-9. PubMed ID: 9243257
[TBL] [Abstract][Full Text] [Related]
14. Expression of thrombin receptors in human atherosclerotic coronary arteries leads to an exaggerated vasoconstrictory response in vitro.
Ku DD; Dai J
J Cardiovasc Pharmacol; 1997 Nov; 30(5):649-57. PubMed ID: 9388048
[TBL] [Abstract][Full Text] [Related]
15. Different effects of thrombin receptor activation on endothelium and smooth muscle cells of human coronary bypass vessels. Implications for venous bypass graft failure.
Yang Z; Ruschitzka F; Rabelink TJ; Noll G; Julmy F; Joch H; Gafner V; Aleksic I; Althaus U; Lüscher TF
Circulation; 1997 Apr; 95(7):1870-6. PubMed ID: 9107175
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of basal but not agonist-stimulated activity of nitric oxide in rat aorta by NG-monomethyl-L-arginine.
Frew JD; Paisley K; Martin W
Br J Pharmacol; 1993 Nov; 110(3):1003-8. PubMed ID: 7507774
[TBL] [Abstract][Full Text] [Related]
17. Argatroban and inhibition of the vasomotor actions of thrombin.
Winn MJ; Jain K; Ku DD
J Cardiovasc Pharmacol; 1993 Nov; 22(5):754-60. PubMed ID: 7506329
[TBL] [Abstract][Full Text] [Related]
18. Interactions of nitric oxide synthase inhibitors and dexamethasone with alpha-adrenoceptor-mediated responses in rat aorta.
Adeagbo AS; Triggle CR
Br J Pharmacol; 1993 Jun; 109(2):495-501. PubMed ID: 7689395
[TBL] [Abstract][Full Text] [Related]
19. Inhibitory role of endothelium-derived relaxing factor in rat and human pulmonary arteries.
Crawley DE; Liu SF; Evans TW; Barnes PJ
Br J Pharmacol; 1990 Sep; 101(1):166-70. PubMed ID: 2282458
[TBL] [Abstract][Full Text] [Related]
20. EDRF release from canine coronary artery by lectins.
Kleha JF; Devesly P; Johns A
Br J Pharmacol; 1993 Dec; 110(4):1473-8. PubMed ID: 8306089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
